DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Haematological Malignancy · Colorectal Neoplasms · Urinary Bladder Neoplasm · Gallbladder Neoplasms · Salivary Gland Neoplasm · Lung Neoplasm · Pancreatic Neoplasm · Ovarian Neoplasms · Prostatic Neoplasm · Skin Neoplasm · Solid Tumour

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Belfast City Hospital, Belfast, United Kingdom
Contact: Study coordinator (Vicky Coyle, Prof) · V.Coyle@qub.ac.uk
Contact: Principal Investigator (Vicky Coyle, Prof)
University Hospital Birmingham, Birmingham, United Kingdom
Contact: Study coordinator (Gary Middleton, Prof) · G.Middleton@bham.ac.uk · 0121 371 3573
Contact: Principal Investigator (Gary Middleton, Prof)
Birmingham Children's Hospital, Birmingham, United Kingdom
Contact: Study coordinator (Gerard Millen, Dr) · g.millen@nhs.net · 07921843607
Contact: Principal Investigator (Gerard Millen, Dr)
Bristol Royal Hospital for Children, Bristol, United Kingdom
Contact: Study coordinator (Antony Ng, Dr) · Antony.Ng@uhbw.nhs.uk · 0117 342 8044
Contact: Principal Investigator (Antony Ng, Dr)
Bristol Haematology and Oncology Centre, Bristol, United Kingdom
Contact: Study coordinator (Antony Ng, Dr) · Antony.Ng@uhbw.nhs.uk · 0117 342 8044
Contact: Principal Investigator (Antony Ng, Dr)
Addenbrooke's Hospital, Cambridge, United Kingdom
Contact: Study coordinator (Bristi Basu, Dr) · bb313@medschl.cam.ac.uk · 01223 596105
Contact: Principal Investigator (Bristi Basu, Dr)
Velindre Cancer Centre, Cardiff, United Kingdom
Contact: Study coordinator (Robert Jones, Dr) · Robert.Hugh.Jones@wales.nhs.uk · 02920 615888
Contact: Principal Investigator (Robert Jones, Dr)
Cardiff Children's Hospital, Cardiff, United Kingdom
Contact: Study coordinator (Madeline Adams, Dr) · madeline.adams@wales.nhs.uk · +442921842285
Contact: Principal Investigator (Madeline Adams, Dr)
Western General Hospital, Edinburgh, United Kingdom
Contact: Study coordinator (Stefan Symeonides, Dr)
Contact: Principal Investigator (Stefan Symeonides, Dr)
The Beatson Hospital, Glasgow, United Kingdom
Contact: Study coordinator (Patricia Roxburgh, Dr) · Patricia.Roxburgh@glasgow.ac.uk · 0141 301 7118
Contact: Principal Investigator (Patricia Roxburgh, Dr)
Royal Hospital for Children Glasgow, Glasgow, United Kingdom
Contact: Study coordinator (Milind Ronghe, Dr) · Milind.Ronghe@ggc.scot.nhs.uk · 0141 452 6692
Contact: Principal Investigator (Milind Ronghe, Dr)
Leicester Royal Infirmary, Leicester, United Kingdom
Contact: Study coordinator (Olubukola Ayodele, Dr) · olubukola.ayodele@uhl-tr.nhs.uk · 0116 2587601
Contact: Principal Investigator (Olubukola Ayodele, Dr)
Alder Hey Hospital, Liverpool, United Kingdom
Contact: Study coordinator (Lisa Howell, Dr) · Lisa.Howell@alderhey.nhs.uk · 0151 293 3679
Contact: Principal Investigator (Lisa Howell, Dr)
University College London Hospital, London, United Kingdom
Contact: Study coordinator (Martin Forster, Prof) · M.Forster@ucl.ac.uk · 020 3447 5085
Contact: Principal Investigator (Martin Forster, Prof)
Guy's Hospital, London, United Kingdom
Contact: Study coordinator (James Spicer, Dr) · james.spicer@kcl.ac.uk · 020 7188 4260
Contact: Principal Investigator (James Spicer, Dr)
Great Ormond Street Hospital, London, United Kingdom
Contact: Study coordinator (Darren Hargrave, Dr) · Darren.hargrave@gosh.nhs.uk · 0207 813 8525
Contact: Principal Investigator (Darren Hargrave, Dr)
Royal Manchester Children's Hospital, Manchester, United Kingdom
Contact: Study coordinator (Guy Makin, Dr) · Guy.Makin@mft.nhs.uk · 0161 701 8419
Contact: Principal Investigator (Guy Makin, Dr)
The Christie Hospital, Manchester, United Kingdom
Contact: Study coordinator (Matthew Krebs, Dr) · matthew.krebs@nhs.net · 0161 918 7672
Contact: Principal Investigator (Matthew Krebs, Dr)
Clatterbridge Cancer Centre, Metropolitan Borough of Wirral, United Kingdom
Contact: Study coordinator (Dan Palmer, Dr) · daniel.palmer@liverpool.ac.uk · 0151 706 4172 / 0151 706 4177
Contact: Principal Investigator (Dan Palmer, Dr)
Great North Children's Hospital, Newcastle, United Kingdom
Contact: Study coordinator (Alastair Greystoke, Dr) · Alastair.Greystoke@newcastle.ac.uk · 0191 2138476
Contact: Principal Investigator (Alastair Greystoke, Dr)
Freeman Hospital, Newcastle, United Kingdom
Contact: Study coordinator (Alastair Greystoke, Dr) · Greystoke@newcastle.ac.uk · 0191 2138476
Contact: Principal Investigator (Alastair Greystoke, Dr)
Churchill Hospital, Oxford, United Kingdom
Contact: Study coordinator (Sarah Pratap, Dr) · Sarah.Pratap@ouh.nhs.uk · 01865 235273
Contact: Principal Investigator (Sarah Pratap, Dr)
John Radcliffe Hospital, Oxford, United Kingdom
Contact: Study coordinator (Sarah Pratap, Dr) · Sarah.Pratap@ouh.nhs.uk · 01865 235273
Contact: Principal Investigator (Sarah Pratap, Dr)
Weston Park Hospital, Sheffield, United Kingdom
Contact: Study coordinator (Sarah Danson, Dr) · s.danson@sheffield.ac.uk · 0114 226 5068
Contact: Principal Investigator (Sarah Danson, Dr)
Sheffield's Children's Hospital, Sheffield, United Kingdom
Contact: Study coordinator (Daniel Yeomanson, Dr) · danyeomanson@nhs.net · 01142717366
Contact: Principal Investigator (Daniel Yeomanson, Dr)
Southampton General Hospital, Southampton, United Kingdom
Contact: Study coordinator (Juliet Gray, Prof) · Juliet.Gray@uhs.nhs.uk · 0238 120 6639
Contact: Principal Investigator (Juliet Gray, Prof)
The Royal Marsden Hospital, Sutton, United Kingdom
Contact: Study coordinator (Lynley Marshall, Dr) · LynleyVanessa.Marshall@icr.ac.uk · 0208 661 3678
Contact: Principal Investigator (Lynley Marshall, Dr)

Study leads

Matthew Krebs, Dr
Principal Investigator
The Christie Hospital

View source on ClinicalTrials.gov